Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$99.47
-0.07%
Mkt Cap $5.00B
Analyst Ratings
Buy
20
Hold
0
Sell
0
Price Target (35 analysts)
$116.70
Range $95.00 – $140.00
Implied Upside
+17.3%
Consensus $116.70 vs current $99.47
NASDAQ·Healthcare·Biotechnology
$99.47
-0.07%
Mkt Cap $5.00B
Buy
20
Hold
0
Sell
0
Price Target (35 analysts)
$116.70
Range $95.00 – $140.00
+17.3%
Consensus $116.70 vs current $99.47